316 results on '"Tham, Wai-Hong"'
Search Results
2. Serological Markers of Exposure to Plasmodium falciparum and Plasmodium vivax Infection in Southwestern Ethiopia.
3. Antibody Fc-binding profiles and ACE2 affinity to SARS-CoV-2 RBD variants
4. The biology and pathogenesis of vivax malaria
5. Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 protein
6. PCRCR complex is essential for invasion of human erythrocytes by Plasmodium falciparum
7. Parallel use of human stem cell lung and heart models provide insights for SARS-CoV-2 treatment
8. Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2
9. Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice
10. Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi
11. Comparison of total immunoglobulin G antibody responses to different protein fragments of Plasmodium vivax Reticulocyte binding protein 2b
12. Naturally acquired antibody kinetics against Plasmodium vivax antigens in people from a low malaria transmission region in western Thailand
13. Potent AMA1-specific human monoclonal antibody against P. vivax Pre-erythrocytic and Blood Stages
14. Plasmodium vivax binds host CD98hc (SLC3A2) to enter immature red blood cells
15. Activity Refinement of Aryl Amino Acetamides that Target the P. Falciparum Star-Related Lipid Transfer 1 Protein
16. Aryl amino acetamides prevent the development ofPlasmodium falciparumrings via inhibition of the lipid transfer protein PfSTART1
17. Naturally acquired blocking human monoclonal antibodies to Plasmodiumvivax reticulocyte binding protein 2b
18. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19
19. Development and validation of serological markers for detecting recent Plasmodium vivax infection
20. Complement Evasion Mechanisms of the Human Pathogen Plasmodium falciparum
21. Evolutionary history of human Plasmodium vivax revealed by genome-wide analyses of related ape parasites
22. Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax
23. Structure of Plasmodium falciparum Rh5–CyRPA–Ripr invasion complex
24. A Genome-Wide Screen Identifies Genes Required for Centromeric Cohesion
25. Plasmodium vivax vaccine research – we’ve only just begun
26. Cryo-EM structure of an essential Plasmodium vivax invasion complex
27. Serological Markers of Exposure to Plasmodium falciparum and Plasmodium vivax Infection in Southwestern Ethiopia
28. Structurally conserved erythrocyte-binding domain in Plasmodium provides a versatile scaffold for alternate receptor engagement
29. Complement Receptor 1 availability on red blood cell surface modulates Plasmodium vivax invasion of human reticulocytes
30. Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2
31. Nanobodies against Pfs230 block Plasmodium falciparum transmission
32. Longitudinal IgG antibody responses to Plasmodium vivax blood-stage antigens during and after acute vivax malaria in individuals living in the Brazilian Amazon
33. Parallel use of pluripotent human stem cell lung and heart models provide new insights for treatment of SARS-CoV-2
34. Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2
35. Altered affinity to ACE2 and reduced Fc functional antibodies to SARS-CoV-2 RBD variants
36. Plasmodium 6-Cysteine Proteins: Functional Diversity, Transmission-Blocking Antibodies and Structural Scaffolds
37. Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax
38. Erythrocyte and reticulocyte binding-like proteins of Plasmodium falciparum
39. Heterologous SARS-CoV-2 IgA neutralising antibody responses in convalescent plasma
40. Additional file 1 of Naturally acquired antibody kinetics against Plasmodium vivax antigens in people from a low malaria transmission region in western Thailand
41. Additional file 2 of Naturally acquired antibody kinetics against Plasmodium vivax antigens in people from a low malaria transmission region in western Thailand
42. Additional file 1 of Comparison of total immunoglobulin G antibody responses to different protein fragments of Plasmodium vivax Reticulocyte binding protein 2b
43. Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand
44. Structure of the Pf12 and Pf41 heterodimeric complex ofPlasmodium falciparum6-cysteine proteins
45. HeterologousSARS‐CoV‐2IgAneutralising antibody responses in convalescent plasma
46. Multimodal imaging reveals membrane skeleton reorganisation during reticulocyte maturation and differences in dimple and rim regions of mature erythrocytes
47. Plasmodium vivax malaria serological exposure markers: assessing the degree and implications of cross-reactivity with P. knowlesi
48. Decision letter: Structural basis of malaria transmission blockade by a monoclonal antibody to gamete fusogen HAP2
49. Naturally acquired antibody kinetics against Plasmodium vivax antigens in people from a low malaria transmission region in western Thailand
50. Editor's evaluation: Highly synergistic combinations of nanobodies that target SARS-CoV-2 and are resistant to escape
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.